Potent, Selective, and Orally Efficacious Antagonists of Melanin-Concentrating Hormone Receptor 1
Tavares, F. X.* et al. J. Med. Chem. 2006, 49, 7095.
6-(4-Chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4 (3H)-one-Based Melanin-Concentrating Hormone
Receptor 1 Antagonist
Tavares, F. X.* et al. J. Med. Chem. 2006, 49, 7108.
N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy
Tavares, F. X.* et al. J. Med. Chem. 2004, 47, 4716.
Editorial
Tavares, F. X.* Curr. Top. Med. Chem. 2005, 5, 1587
Design of cathepsin K inhibitors for osteoporosis
Tavares, F. X.* et al. Curr. Top. Med Chem. 2005, 5, 1639.
Ketoheterocycle-based inhibitors of cathepsin K: A novel entry into the synthesis of peptidic ketoheterocycles
Tavares, F. X.* et al. Bioorg. Med. Chem. Lett. 2005, 15, 3891.
Ketoamide-Based Inhibitors of Cysteine Protease, Cathepsin K: P3 Modifications
Tavares, F. X.* et al. J. Med. Chem. 2004, 47, 5057.
Potent and Selective Ketoamide-Based Inhibitors of Cysteine Protease, Cathepsin K
Tavares, F. X.* et al. J. Med. Chem. 2004, 47, 5049.
Design of Potent, Selective, and Orally Bioavailable Inhibitors of Cysteine
Protease Cathepsin K
Francis X. Tavares, Virginia Boncek, David N. Deaton, Anne M. Hassell, Stacey T. Long, Aaron B. Miller, Alan A. Payne, Larry R. Miller, Lisa M. Shewchuk, Kevin Wells-Knecht, Derril H. Willard Jr, Lois L. Wright, and Hui-Qiang Zhou 12/24/2003
Enantioselective Synthesis of a Taxane C-Ring Component
Using the Schuitz Asymmetric Birch Reduction Methodology
Philip Magnus,* Francis Tavares and Nicholas Westwood 1997
Total synthesis of the streptogramin antibiotic, (-)-Madumycin II
Tavares, F.* Lawson, J. P.; Meyers, A. I. 211th ACS National Meeting, New Orleans, LA, March 24-28, 1996, ORGN-171.